Nuritas, headquartered in Dublin, has already proven it’s up to the task. The startup used AI to discover an ingredient to help treat inflammation which is expected to reach sports nutrition products by the end of 2019.

The debut ingredient was discovered as part of a collaboration with BASF, a German chemical giant. Whereas the standard to discover a new ingredient is between five and seven years using traditional methods, the pair used AI to discover it in just two.

“To have something in market that quickly is just exceedingly disruptive by comparison to what’s normally the case with that particular arena,” Nuritas CEO Emmet Browne told Yahoo Finance UK.

While it’s unclear what the next discoveries will be, Nuritas is expecting five more ingredients within the next 12-18 months. The company’s success rate of 60 percent is far higher than the industry standard.

“In effect, what we do is use artificial intelligence to unlock nature’s secrets. That’s the depth of it.”

Nuritas has raised £40 million from a series of high-profile investors which includes Salesforce founder Marc Benioff, and U2’s Bono and the Edge.

AI is being increasingly used in healthcare in life-changing (and often life-saving!) ways. You can find all our AI in healthcare coverage here.

deepgeniusai.com/">AI & Big Data Expo events with upcoming shows in Silicon Valley, London, and Amsterdam to learn more. Co-located with the IoT Tech Expo, , & .

The post AI health startup Nuritas expects to discover five new drugs by 2021 appeared first on AI News.